EUVIMEDEUVIMED entdecken
Übersichtsarbeit

COVID-19 as a Risk Factor for Alzheimer’s Disease

Mahdieh Golzari-Sorkheh, Donald F Weaver, Mark A Reed

Journal of Alzheimer's Disease · 03.01.2023 · 91 (1) · 1-23

DOI: 10.3233/jad-220800 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Alzheimer's Disease, erschienen am 03.01.2023. Verfasst von Mahdieh Golzari-Sorkheh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: COVID-19, Alzheimer Disease, Nervous System Diseases. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 255 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe acute respiratory disease coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19) pandemic. Although a primarily respiratory disease, recent reports indicate that it also affects the central nervous system (CNS). Over 25% of COVID-19 patients report neurological symptoms such as memory loss, anosmia, hyposmia, confusion, and headaches. The neurological outcomes may be a result of viral entry into the CNS and/or resulting neuroinflammation, both of which underlie an elevated risk for Alzheimer’s disease (AD). Herein, we ask: Is COVID-19 a risk factor for AD? To answer, we identify the literature and review mechanisms by which COVID-19-mediated neuroinflammation can contribute to the development of AD, evaluate the effects of acute versus chronic phases of infection, and lastly, discuss potential therapeutics to address the rising rates of COVID-19 neurological sequelae.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Alzheimer DiseaseNervous System DiseasesHumansSARS-CoV-2Neuroinflammatory DiseasesRisk Factors

Stichwörter der Autor:innen

Alzheimer’s diseaseCOVID-19dementialong COVIDneuroinflammation

Autor:innen und Institutionen

  • Department of Immunology, University of Toronto, Toronto, ON, Canada.
  • Krembil Research Institute, University Health Network, Toronto, ON, Canada.
  • Department of Chemistry, University of Toronto, Toronto, ON, Canada.
  • Department of Pharmaceutical Chemistry, University of Toronto, Toronto, ON, Canada.
  • Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.

Zitieren

APA

Golzari-Sorkheh, M., Weaver, D. F., & Reed, M. A. (2023). COVID-19 as a Risk Factor for Alzheimer’s Disease. Journal of Alzheimer's Disease, 91(1), 1-23. https://doi.org/10.3233/jad-220800

Vancouver

Golzari-Sorkheh M, Weaver DF, Reed MA. COVID-19 as a Risk Factor for Alzheimer’s Disease. Journal of Alzheimer's Disease. 2023;91(1):1-23. doi:10.3233/jad-220800

BibTeX
@article{GolzariSorkheh2023,
  author = {Golzari-Sorkheh, Mahdieh and Weaver, Donald F and Reed, Mark A},
  title = {COVID-19 as a Risk Factor for Alzheimer’s Disease},
  journal = {Journal of Alzheimer's Disease},
  year = {2023},
  volume = {91},
  number = {1},
  pages = {1--23},
  doi = {10.3233/jad-220800}
}
Kostenlos starten →